Medication Training Via Ignite Based on Roy Model in Heart Failure: Medication Adherence and Symptom Management

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSaglik Bilimleri Universitesi

About this trial

The goal of this clinical trial is to learn if a structured medication training program can help people with heart failure better manage their condition. The program is based on the Roy Adaptation Model and is designed to support how people adjust to their illness.

The main questions it aims to answer are:

Does the training program improve heart failure symptoms? Does the training program help participants take their medications as prescribed?

Researchers will compare a training program group to a control group receiving standard care to see if the program is effective.

Participants will:

Be randomly assigned to either a training program group or a control group Receive the training program through WhatsApp after hospital discharge or receive standard discharge education Be followed for 12 weeks Complete questionnaires at the start of the study, at 4 weeks, and at 12 weeks

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Must be 18 years of age or older.

Individuals who are willing to participate in the study

No communication problems

Having been diagnosed with KY for at least 6 months

Disqualifiers

Not being willing to participate in the study don't be under the age of 18

Lack of ability to read, write and speak Turkish

Low ejection fraction (left ventricle EF. 40%)

Preserved ejection fraction (left ventricular EF.50%)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ignite-Based Medication Management Training

    Other intervention

    The intervention is a structured medication management training program based on the Roy Adaptation Model. It is delivered using an Ignite digital presentation format and sent to participants via WhatsApp. The content is developed using current evidence-based heart failure guidelines (AHA and ESC) and focuses on improving patients' adaptation to illness through four adaptive modes (physiological, self-concept, role function, and interdependence). Participants receive the training after discharge and are followed up at 4 and 12 weeks using standardized symptom and medication adherence scales.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Control Group - Standard CareNo intervention 0 interventions
Group B: Intervention Group - Ignite-Based Medication TrainingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Heart Failure Symptom Status Scale

This scale is used to assess the symptom burden associated with heart failure. Total scores range from 0 to 84, with higher scores indicating poorer health status and lower scores indicating better health status.

Time frame
20 minutes

Secondary outcomes

1

Medication Adherence Report Scale

This scale is used to assess medication adherence. Total scores range from 5 to 25, with higher scores indicating better adherence and lower scores indicating poorer adherence.

Time frame
5 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: